Establishment of prediction and prevention method for bleeding complication after left ventricular assist device implantation

Establishment of prediction and prevention method for bleeding complication after left ventricular assist device implantation - LVADAVWS Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027761

Enrollment

200

Registered

2017-06-14

Start date

2017-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with LVAD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases after LVAD implantation

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
VWF multimer analysis, platelet surface protein analysis and platelet aggregation test are performed on the blood sample before and after LVAD implantation.	—

Secondary

Measure	Time frame
We acquire clinical data before and after LVAD implantation from the database of J-MACS registry. Specific datas are as follows. 1) Medical history, diagnosis 2) Electrocardiogram 3) Blood sampling test 4) Echocardiography	—

Countries

Japan

Contacts

Public ContactKo Sakatsume

Tohoku University Graduate School of Medicine Division of Cardiovascular Surgery

kosakatsume@gmail.com022-717-7222

Outcome results